Living-donor Kidney Transplantation After Resection of Mixed Epithelial and Stromal Tumor: A Positive Outcome Despite Not Observing the Recommended Waiting Period
Cancer Diagnosis & Prognosis · 01.07.2026 · 6 (4) · 674-681
DOI: 10.21873/cdp.10567 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Diagnosis & Prognosis, online erschienen am 01.07.2026. Verfasst von Keisuke Nakai und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background/Aim: Mixed epithelial and stromal tumor (MEST) is a benign renal neoplasm. For MEST cases requiring kidney transplantation, a waiting period is essential. However, reports on the management of MEST cases awaiting kidney transplantation are limited. We report the case of a patient with end-stage renal disease and bilateral renal pelvic tumors who was pathologically diagnosed with MEST and successfully underwent living-donor kidney transplantation without the recommended waiting period. Case Report: A 52-year-old woman had been diagnosed with mesangial proliferative glomerulonephritis 10 years earlier. Her renal function had gradually declined, and maintenance hemodialysis had been initiated 1 year before referral to us. She preferred living-donor kidney transplantation and was referred to our hospital after computed tomography at a previous institution revealed bilateral renal pelvic masses with well-defined margins and contrast enhancement. Voided urine cytology was classified as atypical urothelial cells. At the patient’s request, ureteroscopic examination was not performed. For diagnostic and therapeutic purposes, robot-assisted left nephroureterectomy was performed. Histopathological examination revealed MEST, and this was confirmed via the histopathological examination of the right-sided lesion. Based on this diagnosis, right nephroureterectomy, followed by living-donor kidney transplantation up to the right iliac fossa, was performed 6 months after the left nephroureterectomy. The postoperative course was uneventful, and the patient was discharged on postoperative day 9. No evidence of recurrence or metastasis has been observed during 1 year of follow-up. Conclusion: This case demonstrates that living-donor kidney transplantation without a mandatory waiting period may benefit patients with end-stage renal disease when a definitive diagnosis of MEST is established before transplantation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
- Department of Surgical Pathology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
- Department of Organ Transplantation Medicine, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Zitieren
APA
Nakai, K., Kobari, Y., Hakozaki, M., Ikeda, T., Saito, A., Okada, D., Wada, A., Fukuda, H., Nakayama, T., Unagami, K., Yoshida, K., Hirai, T., Shimizu, T., Iizuka, J., Ishida, H., Nagashima, Y., & Takagi, T. (2026). Living-donor Kidney Transplantation After Resection of Mixed Epithelial and Stromal Tumor: A Positive Outcome Despite Not Observing the Recommended Waiting Period. Cancer Diagnosis & Prognosis, 6(4), 674-681. https://doi.org/10.21873/cdp.10567
Vancouver
Nakai K, Kobari Y, Hakozaki M, Ikeda T, Saito A, Okada D, et al. Living-donor Kidney Transplantation After Resection of Mixed Epithelial and Stromal Tumor: A Positive Outcome Despite Not Observing the Recommended Waiting Period. Cancer Diagnosis & Prognosis. 2026;6(4):674-681. doi:10.21873/cdp.10567
BibTeX
@article{Nakai2026,
author = {Nakai, Keisuke and Kobari, Yuki and Hakozaki, Mayu and Ikeda, Takashi and Saito, Ayaka and Okada, Daigo and Wada, Arisa and Fukuda, Hironori and Nakayama, Takayuki and Unagami, Kohei and Yoshida, Kazuhiko and Hirai, Toshihito and Shimizu, Tomokazu and Iizuka, Junpei and Ishida, Hideki and Nagashima, Yoji and Takagi, Toshio},
title = {Living-donor Kidney Transplantation After Resection of Mixed Epithelial and Stromal Tumor: A Positive Outcome Despite Not Observing the Recommended Waiting Period},
journal = {Cancer Diagnosis & Prognosis},
year = {2026},
volume = {6},
number = {4},
pages = {674--681},
doi = {10.21873/cdp.10567}
}
EUVIMED